New data demonstrates EmtinB activity in autoimmune diseases

Mar 11, 2022 at 2:39 AM UTC · Issued by Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd has released a press release.